News + Font Resize -

Teva gets FDA nod for polyethylene glycol 3350 NF for oral solution
Jerusalem, Israel | Monday, May 15, 2006, 08:00 Hrs  [IST]

The US FDA has granted final approval for Teva Pharmaceutical Industries ANDA for polyethylene glycol 3350 NF for oral solution, 17 gram/scoopful.

Teva's Polyethylene Glycol 3350 NF for oral solution is the AB-rated generic equivalent of Braintree's Miralax for oral solution, a product indicated for the treatment of occasional constipation.

Total annual sales of Polyethylene Glycol 3350 NF for oral solution are approximately $153 million.

Post Your Comment

 

Enquiry Form